Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Microcirculatory Blood Flow in Systemic Sclerosis
NCT01347008Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Apr 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in Raynaud phenomenon, sponsored by Federal University of São Paulo. Started Apr 2011; status: completed.
02
Drugs
ASP-001
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT01347008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347008.